<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="495715c9-fe7d-4b18-9bcf-9f60e66cf6c8"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Gwen Ifill</title>
  <effectiveTime value="20260224120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="195c55f8-0368-4141-8f16-d5ed19b0897a"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="b2dcde60-345c-46e2-adb6-1cee7d8b4f74" extension="HR-ML032-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-32-5814"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Gwen</given><family>Ifill</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19650929"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260224120000-0500"/>
    <assignedAuthor><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260224120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="98a6bc70-792b-4bce-a13e-79868dd95196"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Review three weeks after surgical staging: final pathology and molecular class, genetic counseling, and the first cycle of dostarlimab with carboplatin and paclitaxel</originalText></code>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="65a6e1dc-89af-442a-bade-415b3ef897e1"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Lorna</given><family>Achebe-Price</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Review three weeks after surgical staging, on the first treatment day. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Ifill returns three weeks after robotic-assisted hysterectomy with removal of both tubes and ovaries, sentinel node mapping and removal of the enlarged para-aortic node. She went home the next morning, needed acetaminophen for about a week and nothing since, and has had no bleeding, fever, leg swelling or bladder trouble. She went back to work last week. The final pathology and molecular results are back, and the multidisciplinary tumor board reviewed them with Dr. Delacroix. She saw the genetic counselor this morning. She came today for her first cycle of dostarlimab with carboplatin and paclitaxel. She has had no thoughts of self-harm. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Operation</td><td>Minimally invasive; home the next day; port sites healed</td></tr><tr><td>Pathology</td><td>Endometrioid adenocarcinoma, grade 2, 65% myometrial invasion; right pelvic sentinel node and one para-aortic node involved</td></tr><tr><td>Stage and molecular class</td><td>FIGO 2023 stage IIIC2ii; POLE wild-type, MMRd, p53 wild-type</td></tr><tr><td>Lynch syndrome screen</td><td>MLH1 promoter hypermethylated: acquired, not inherited</td></tr><tr><td>Today</td><td>Cycle 1 of dostarlimab, carboplatin and paclitaxel</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No fever; weight 72.6 kg</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>No vaginal bleeding or discharge; no urinary symptoms</td></tr><tr><td>Gastrointestinal</td><td>Negative</td><td>No nausea, diarrhea or abdominal pain</td></tr><tr><td>Neurological</td><td>Negative</td><td>No tingling or numbness in the hands or feet</td></tr><tr><td>Cardiovascular</td><td>Negative</td><td>No calf pain or leg swelling</td></tr><tr><td>Integumentary</td><td>Negative</td><td>No rash</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood steady; PHQ-9 5; no thoughts of self-harm</td></tr></tbody></table><paragraph>7 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day</td><td>Two tablets every 6 hours as needed</td><td>Oral route</td><td>2026-02-03 to 2026-02-17</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Dostarlimab 50 mg/mL injection, 500 mg intravenously over 30 minutes on day 1 of each 21-day cycle, before carboplatin and paclitaxel, for six cycles</td><td>Day 1 every 21 days for six cycles</td><td>Intravenous route</td><td>2026-02-24 to 2026-06-09</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Carboplatin 10 mg/mL injection, 575 mg (AUC 5) intravenously on day 1 of each 21-day cycle, for six cycles</td><td>Day 1 every 21 days for six cycles</td><td>Intravenous route</td><td>2026-02-24 to 2026-06-09</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Paclitaxel 6 mg/mL injection, 320 mg (175 mg/m2) intravenously over 3 hours on day 1 of each 21-day cycle, for six cycles, after dexamethasone, diphenhydramine and famotidine</td><td>Day 1 every 21 days for six cycles</td><td>Intravenous route</td><td>2026-02-24 to 2026-06-09</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea</td><td>One tablet every 8 hours as needed for nausea</td><td>Oral route</td><td>2026-02-24 to 2026-06-30</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="83594145-b2b7-475c-8a32-66523ff7ff60"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260203"/><high value="20260217"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="67d479aa-3740-4f59-9cf1-3827eba9bda5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9d3a5b71-00a8-4b90-94d8-05f23c7cb4e1"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260609"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="500" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2539972" codeSystem="2.16.840.1.113883.6.88" displayName="10 ML dostarlimab-gxly 50 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="59ba6e1d-6b4b-46f9-a0f1-d815338abdbb"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="a1326237-7bd1-41a7-8b2d-66469a571331"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="04d491e5-f059-4375-832b-95a0604a9547"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260609"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="575" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="597195" codeSystem="2.16.840.1.113883.6.88" displayName="carboplatin 10 MG/ML Injectable Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="22b03f15-8910-4e18-a882-7a6642cc8803"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6d9bd01f-c76c-46d2-8835-4adb9ff36654"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="287401b0-74fa-4cde-b764-eea00a00b92d"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260609"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="21" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="320" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="312199" codeSystem="2.16.840.1.113883.6.88" displayName="paclitaxel 6 MG/ML Injectable Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6d978dca-7bec-4f67-8904-907322210f1d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3e7983a7-43da-4a31-95cc-f61ecee094ab"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="5d1f83ce-a5ca-4a8f-8986-199e14166ab4"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260224"/><high value="20260630"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="312086" codeSystem="2.16.840.1.113883.6.88" displayName="ondansetron 8 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f1561978-30d9-4663-bd5c-da18417a023c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="62a13adb-79b6-4818-89a7-5d5351b98bd7"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260105"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="4c1431c9-5a66-421e-b409-53512b4308d7"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>2026-02-24</td><td>Body height</td><td>165</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>2026-02-24</td><td>Body weight</td><td>72.6</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>2026-02-24</td><td>Body mass index (BMI) [Ratio]</td><td>26.7</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>2026-02-24</td><td>Systolic blood pressure</td><td>124</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>2026-02-24</td><td>Diastolic blood pressure</td><td>78</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>2026-02-24</td><td>Heart rate</td><td>80</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>2026-02-24</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>2026-02-24</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>2026-02-24</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>99</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="dcceec39-4b91-44e6-930c-fdf4d1103d4a"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260224"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="2b3c9e92-05a8-4fb2-a37e-daeb5359a6d4"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="165" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="6a488995-041f-4395-82c7-a1721b113f8a"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="72.6" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="9401428a-b820-4d80-954c-417007df547d"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="26.7" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a699ee10-be66-4d76-a230-cdf9b9a8a043"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="124" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="bef69426-9046-4c05-8c03-a20d80e3bc93"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="78" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="7cee1bc4-4629-47d7-8032-048a4b2bdb5d"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="80" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1e2d4fa0-edca-48ee-a68c-df3f2e3ae29c"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ef2efcc0-7c33-4cd7-a252-16f19ef5692c"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5635e712-7a72-489e-a4bc-84b39962ab4c"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="20260224"/><value xsi:type="PQ" value="99" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-24"><td>2026-02-24</td><td>Hemoglobin [Mass/volume] in Blood</td><td>11.6</td><td>g/dL</td><td>12-15.5 g/dL</td><td>Low</td><td>S</td></tr>
  <tr ID="result-25"><td>2026-02-24</td><td>Leukocytes [#/volume] in Blood by Automated count</td><td>6.4</td><td>10*3/uL</td><td>4-11 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-26"><td>2026-02-24</td><td>Neutrophils [#/volume] in Blood by Automated count</td><td>3.9</td><td>10*3/uL</td><td>1.5-7.7 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-27"><td>2026-02-24</td><td>Platelets [#/volume] in Blood by Automated count</td><td>301</td><td>10*3/uL</td><td>150-400 10*3/uL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-28"><td>2026-02-24</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>0.78</td><td>mg/dL</td><td>0.59-1.04 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-29"><td>2026-02-24</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>87</td><td>mL/min/{1.73_m2}</td><td>&gt;=60 mL/min/1.73 m²</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-30"><td>2026-02-24</td><td>Glucose [Mass/volume] in Serum or Plasma</td><td>92</td><td>mg/dL</td><td>70-99 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-31"><td>2026-02-24</td><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>18</td><td>U/L</td><td>7-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-32"><td>2026-02-24</td><td>Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>20</td><td>U/L</td><td>8-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-33"><td>2026-02-24</td><td>Bilirubin.total [Mass/volume] in Serum or Plasma</td><td>0.4</td><td>mg/dL</td><td>0.1-1.2 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-34"><td>2026-02-24</td><td>Albumin [Mass/volume] in Serum or Plasma</td><td>4</td><td>g/dL</td><td>3.5-5 g/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-35"><td>2026-02-24</td><td>Magnesium [Mass/volume] in Serum or Plasma</td><td>2</td><td>mg/dL</td><td>1.7-2.2 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-36"><td>2026-02-24</td><td>Thyrotropin [Units/volume] in Serum or Plasma</td><td>1.9</td><td>m[IU]/L</td><td>0.4-4.5 mIU/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-37"><td>2026-02-24</td><td>Thyroxine (T4) free [Mass/volume] in Serum or Plasma</td><td>1.2</td><td>ng/dL</td><td>0.8-1.8 ng/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-38"><td>2026-02-24</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>5</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="26893221-7cf5-4656-b2f1-6ad24dc288d0"/>
      <code code="58410-2" codeSystem="2.16.840.1.113883.6.1" displayName="CBC panel - Blood by Automated count"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="09c4fb99-2cc8-4fbc-b436-d7b70ad3ae93"/>
          <code code="718-7" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin [Mass/volume] in Blood"/>
          <text><reference value="#result-24"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="11.6" unit="g/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>12-15.5 g/dL</text>
              <value xsi:type="IVL_PQ"><low value="12" unit="g/dL"/><high value="15.5" unit="g/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="630004da-56b5-45e1-8c67-da4013082a25"/>
          <code code="6690-2" codeSystem="2.16.840.1.113883.6.1" displayName="Leukocytes [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-25"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="6.4" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>4-11 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="4" unit="10*3/uL"/><high value="11" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="17c84d9d-5c1a-4257-8e6d-5bab794fa8da"/>
          <code code="751-8" codeSystem="2.16.840.1.113883.6.1" displayName="Neutrophils [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="3.9" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>1.5-7.7 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="1.5" unit="10*3/uL"/><high value="7.7" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="05d01aeb-b56e-4104-b426-305e1f7ae707"/>
          <code code="777-3" codeSystem="2.16.840.1.113883.6.1" displayName="Platelets [#/volume] in Blood by Automated count"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="301" unit="10*3/uL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>150-400 10*3/uL</text>
              <value xsi:type="IVL_PQ"><low value="150" unit="10*3/uL"/><high value="400" unit="10*3/uL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="38e751d9-4a9b-4d05-b63b-858372d87dbc"/>
      <code code="24323-8" codeSystem="2.16.840.1.113883.6.1" displayName="Comprehensive metabolic 2000 panel - Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="8d8fc7a3-b42d-450b-88df-63848b1319e7"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-28"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="0.78" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.59-1.04 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.59" unit="mg/dL"/><high value="1.04" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="ed7e53ee-c16a-4607-8ef8-5b301e86df19"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="87" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=60 mL/min/1.73 m²</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="24fe1f40-f5e5-422f-9d6b-f2659a10e71d"/>
          <code code="2345-7" codeSystem="2.16.840.1.113883.6.1" displayName="Glucose [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-30"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="92" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>70-99 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="70" unit="mg/dL"/><high value="99" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="e0dd6d8a-1b1e-4c4c-afe9-be7d4044d14a"/>
          <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-31"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="18" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>7-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="7" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="20702b7f-c7ff-4f83-bcbc-246c0a7b2a09"/>
          <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-32"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="20" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>8-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="8" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="dd0504e5-5287-4a6a-907a-cc26b8a080e0"/>
          <code code="1975-2" codeSystem="2.16.840.1.113883.6.1" displayName="Bilirubin.total [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-33"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="0.4" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.1-1.2 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.1" unit="mg/dL"/><high value="1.2" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="93d5e2d9-00b1-4eb7-8ee3-69b18f0397b4"/>
          <code code="1751-7" codeSystem="2.16.840.1.113883.6.1" displayName="Albumin [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-34"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="4" unit="g/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>3.5-5 g/dL</text>
              <value xsi:type="IVL_PQ"><low value="3.5" unit="g/dL"/><high value="5" unit="g/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="bb15acb3-044b-4291-9e01-6cc993c00365"/>
      <code code="19123-9" codeSystem="2.16.840.1.113883.6.1" displayName="Magnesium [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="9c3d05ce-d0a6-4742-8428-6346fe18805f"/>
          <code code="19123-9" codeSystem="2.16.840.1.113883.6.1" displayName="Magnesium [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-35"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="2" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>1.7-2.2 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="1.7" unit="mg/dL"/><high value="2.2" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="e72f4759-510d-4a20-8015-32f3bfd5e9f5"/>
      <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="283c94f9-96d0-4337-81de-d8ad8db3584b"/>
          <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
          <text><reference value="#result-36"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="1.9" unit="m[IU]/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.4-4.5 mIU/L</text>
              <value xsi:type="IVL_PQ"><low value="0.4" unit="m[IU]/L"/><high value="4.5" unit="m[IU]/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="6950a0f9-4755-49d7-8985-e2729727745f"/>
      <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="91c37faa-3813-48ce-b3a1-6a5693115e53"/>
          <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-37"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="1.2" unit="ng/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.8-1.8 ng/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.8" unit="ng/dL"/><high value="1.8" unit="ng/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="d461cbc9-473c-41d4-ba6a-9c38b894ec97"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260224"/><high value="20260224"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="542c6513-8801-41a1-9939-b02f93b6d2d8"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-38"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260224"/>
          <value xsi:type="PQ" value="5" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-02-24; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; blood pressure 124/78, pulse 80; weight 72.6 kg</td></tr><tr><td>Abdomen</td><td>Port-site incisions healed without redness or hernia; soft, non-tender</td></tr><tr><td>Extremities</td><td>No leg or genital swelling; calf circumferences equal (baseline for lymphedema)</td></tr><tr><td>Neurological</td><td>Light touch, pinprick and vibration normal in the hands and feet; ankle reflexes present (baseline before paclitaxel)</td></tr><tr><td>Skin</td><td>No rash (baseline before a checkpoint inhibitor)</td></tr><tr><td>Psychiatric</td><td>Focused and well informed; asks detailed questions</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Postmenopausal bleeding for three weeks, about eight years after her last period, in a woman of 60 who takes no hormone therapy: endometrial cancer must be excluded. Office endometrial biopsy taken today, transvaginal ultrasound this week, and gynecologic oncology review booked</td><td>resolved</td><td>confirmed</td>
    <td>N95.0</td><td>S — Synthetic presenting problem; no symptom of her real illness was made public. Superseded by the diagnosis at the gynecologic oncology consultation.</td>
  </tr>
  <tr ID="problem-2">
    <td>Endometrioid adenocarcinoma of the endometrium, FIGO grade 2, mismatch repair deficient (loss of MLH1 and PMS2 staining), p53 wild-type pattern, on office endometrial biopsy, with enlarged right pelvic and para-aortic lymph nodes on CT; surgical staging planned; synthetic modern detail linked to her publicly reported endometrial cancer</td><td>active</td><td>confirmed</td>
    <td>C54.1</td><td>S — Synthetic histology, molecular result and extent; her family gave endometrial cancer as the cause of death (D), and nothing more about it was made public.</td>
  </tr>
  <tr ID="problem-3">
    <td>Metastatic endometrioid carcinoma in the right external iliac sentinel lymph node (9 mm deposit) and a left para-aortic lymph node (14 mm deposit), with the other nodes removed negative: FIGO 2023 stage IIIC2ii</td><td>active</td><td>confirmed</td>
    <td>C77.8</td><td>S — Synthetic nodal disease found at surgical staging.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b42dc53d-d058-455e-9f4d-83ed45544f8b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260105"/><high value="20260120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c96763e9-c991-42b6-91c0-16e501265378"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260105"/><high value="20260120"/></effectiveTime>
          <value xsi:type="CD" code="N95.0" codeSystem="2.16.840.1.113883.6.90" displayName="Postmenopausal bleeding"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="73bec413-d1e2-487c-bf2b-d38fdd2c96e0"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="38cc1af5-b25d-4031-8aa0-7d9065c9f36e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260120"/></effectiveTime>
          <value xsi:type="CD" code="C54.1" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endometrium"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="39e9f6e5-ccd6-4b98-b85f-cf6ce437cfe8"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260224"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="6b87f1a4-34c9-4a5d-a010-ba49eb3beba4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260224"/></effectiveTime>
          <value xsi:type="CD" code="C77.8" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Endometrioid endometrial cancer, FIGO 2023 stage IIIC2ii, molecular class MMRd (C54.1)</content>. Surgery confirmed nodal spread to the pelvis and the para-aortic region, stage IIIC2ii; the molecular class does not change the stage at stage III but chooses the treatment. For mismatch repair deficient advanced disease, adding a PD-1 inhibitor to carboplatin and paclitaxel greatly lowers the risk of progression, so the tumor board recommends dostarlimab with chemotherapy for six cycles, then dostarlimab alone. Radiation is not planned now and will be reconsidered only if the end-of-treatment CT shows residual nodal disease. Hepatitis B, hepatitis C and HIV tests were negative. Counts, kidney and liver function, magnesium, TSH and free T4 allow full-dose treatment: creatinine 0.78 mg/dL, estimated creatinine clearance about 90 mL/min. [S]<list><item>Cycle 1 today: dostarlimab 500 mg, then carboplatin AUC 5 (575 mg) and paclitaxel 175 mg/m2 (320 mg), every 21 days for six cycles.</item><item>Fosaprepitant, palonosetron and dexamethasone before each cycle; ondansetron at home as needed.</item><item>Temperature twice a day for a week after each cycle; call at once for 38.0 °C or more.</item><item>Report diarrhea, rash, cough, breathlessness or unusual tiredness at once: possible immune-related effects.</item></list></item><item><content styleCode="Bold">Pelvic and para-aortic nodal metastases (C77.8)</content>. Both enlarged nodes removed; no other node involved. Lymphedema risk is low after sentinel mapping but not zero after para-aortic node removal. [S]<list><item>Lymphedema check at each visit; report leg or genital swelling.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Surgical pathology, stage and molecular class</td><td>After surgery</td><td>Up to date</td><td>FIGO 2023 stage IIIC2ii; POLE wild-type, MMRd, p53 wild-type; estrogen receptor positive</td></tr><tr><td>Laboratory</td><td>MLH1 promoter methylation</td><td>Reflex when MLH1 is lost</td><td>Up to date</td><td>Hypermethylated: the mismatch repair loss is acquired in the tumor</td></tr><tr><td>Referral</td><td>Genetic counseling</td><td>When the tumor screen is abnormal</td><td>Completed today</td><td>Seen this morning; the result was explained</td></tr><tr><td>Laboratory</td><td>Germline testing for Lynch syndrome and cascade testing of relatives</td><td>If MMR loss is not explained by MLH1 methylation, or with a strong family history</td><td>Not indicated</td><td>MLH1 loss is explained by promoter methylation; she knows that a new family history of colorectal or endometrial cancer at a young age would be a reason to revisit this</td></tr><tr><td>Laboratory</td><td>Hepatitis B, hepatitis C and HIV screening</td><td>Before systemic cancer treatment</td><td>Up to date</td><td>All negative; no antiviral prophylaxis needed</td></tr><tr><td>Laboratory</td><td>Blood count with neutrophils and platelets</td><td>Before each chemotherapy cycle</td><td>Completed today</td><td>Hemoglobin 11.6 g/dL, white cells 6.4, neutrophils 3.9, platelets 301</td></tr><tr><td>Laboratory</td><td>Creatinine and estimated kidney function (carboplatin dose)</td><td>Before each cycle</td><td>Completed today</td><td>Creatinine 0.78 mg/dL, eGFR 87; carboplatin 575 mg for AUC 5</td></tr><tr><td>Laboratory</td><td>Liver tests (paclitaxel and checkpoint inhibitor)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>ALT 18, AST 20 U/L, bilirubin 0.4 mg/dL, albumin 4.0 g/dL</td></tr><tr><td>Laboratory</td><td>Magnesium</td><td>Before each cycle</td><td>Completed today</td><td>2.0 mg/dL</td></tr><tr><td>Laboratory</td><td>TSH and free T4 (immune-related thyroid disease)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>TSH 1.9 mIU/L, free T4 1.2 ng/dL (baseline)</td></tr><tr><td>Laboratory</td><td>Glucose (immune-related diabetes)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Completed today</td><td>92 mg/dL (baseline)</td></tr><tr><td>Laboratory</td><td>Morning cortisol (immune-related adrenal and pituitary disease)</td><td>Baseline and before each checkpoint inhibitor dose</td><td>Deferred</td><td>Not drawn: she arrived after the morning window, when a cortisol cannot be read. To be drawn before 9 a.m. before cycle 2 in the infusion center. No symptom of adrenal insufficiency</td></tr><tr><td>Examination</td><td>Peripheral neuropathy: symptoms and examination</td><td>Baseline and before each taxane cycle</td><td>Completed today</td><td>Baseline normal before the first paclitaxel dose</td></tr><tr><td>Examination</td><td>Lymphedema</td><td>Each visit after lymph node surgery</td><td>Completed today</td><td>No swelling; baseline calf measurements recorded</td></tr><tr><td>Medication safety</td><td>Nausea and vomiting control</td><td>Each cycle</td><td>Completed today</td><td>Three-drug preventive regimen for carboplatin (an NK1 antagonist, a 5-HT3 antagonist and dexamethasone); ondansetron at home</td></tr><tr><td>Medication safety</td><td>Paclitaxel infusion reaction prevention</td><td>Each paclitaxel dose</td><td>Completed today</td><td>Dexamethasone, diphenhydramine and famotidine before the infusion; observation in the first hour</td></tr><tr><td>Medication safety</td><td>Immune-related adverse event teaching</td><td>Before the first checkpoint inhibitor dose and each visit</td><td>Completed today</td><td>Wallet card and written list of symptoms to report the same day</td></tr><tr><td>Survey</td><td>Distress and depression screen (PHQ-9)</td><td>At diagnosis, each treatment phase, and when symptoms change</td><td>Completed today</td><td>PHQ-9 5; no thoughts of self-harm</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Endometrial tissue diagnosis and ultrasound within one week, and a gynecologic oncology plan within three weeks of presentation. Outcome by 2026-01-20: Biopsy at the first visit, ultrasound in two days, result in four days, CT in eight, consultation at two weeks [S]</item><item>Surgical staging within four weeks of diagnosis. Outcome by 2026-02-24: Minimally invasive hysterectomy with sentinel node mapping and para-aortic node removal two weeks after the consultation [S]</item><item>Six cycles of dostarlimab with carboplatin and paclitaxel every three weeks without a delay of more than one week. In progress; target 2026-06-30 [S]</item><item>Lynch syndrome tumor screening completed and explained before treatment starts. Outcome by 2026-02-24: MLH1 promoter hypermethylation found: acquired, not inherited; genetic counseling done [S]</item><item>Immune-related adverse events found early: TSH, liver tests, glucose and cortisol checked on schedule. In progress; target 2026-06-30 [S]</item><item>PHQ-9 below 10 throughout treatment, with support she chooses. In progress; target 2026-06-30 [S]</item></list><paragraph>Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms (2026); Berek JS, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 2023;162(2):383-394 (PMID 37337978) (2023); Mirza MR, et al. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer (RUBY). N Engl J Med 2023;388(23):2145-2158 (PMID 36972026) (2023); Eskander RN, et al. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer (NRG-GY018). N Engl J Med 2023;388(23):2159-2170 (PMID 36972022) (2023); JEMPERLI (dostarlimab-gxly) injection, prescribing information (2026); Salani R, et al. Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement. Gynecol Oncol 2026;204:109-117 (PMID 41308226) (2026); ACOG Practice Bulletin No. 147: Lynch syndrome. Obstet Gynecol 2014;124(5):1042-1054 (PMID 25437740) (2014); Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392) (2021); Hesketh PJ, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol 2020;38(24):2782-2797 (2020); Loprinzi CL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 2020;38(28):3325-3348 (2020); Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020 (2020); CMID: Clinical Monitoring Intelligence Database, endometrial cancer and hypothyroidism monographs (2026); Depression and Suicide Risk in Adults: Screening (2023)</paragraph><paragraph>Follow-up: Cycles every 21 days in the infusion center, with blood counts, chemistry, TSH and a morning cortisol before cycle 2. Primary care and gynecologic oncology review at cycle 4. Call at once for a temperature of 38.0 °C or more, diarrhea, rash, cough or breathlessness. Next scheduled visit 2026-04-28: midpoint of combination treatment: blood counts, immune-related adverse event checks, neuropathy, and mood. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
